Bulletin
Investor Alert

Bio-Techne Corp.

NAS: TECH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 7, 2020, 4:45 p.m.

/zigman2/quotes/203973516/composite

$

265.76

Change

0.00 0.00%

Volume

Volume 4,703

Quotes are delayed by 20 min

/zigman2/quotes/203973516/composite

Previous close

$ 266.55

$ 265.76

Change

-0.79 -0.30%

Day low

Day high

$262.66

$270.05

Open

52 week low

52 week high

$155.17

$286.68

Open

Insider Actions for Bio-Techne Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/03/2020 Julie L. Bushman
Director
89   Award at $0 per share. 0
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
74   Disposition at $278.84 per share. 20,634
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
2,746   Disposition at $278.06 per share. 763,552
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
1,954   Disposition at $277.28 per share. 541,805
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
400   Disposition at $276.02 per share. 110,408
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
918   Disposition at $274.8 per share. 252,266
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
2,042   Disposition at $273.33 per share. 558,139
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
505   Disposition at $272.48 per share. 137,602
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
440   Disposition at $270.97 per share. 119,226
07/09/2020 Brenda Swierenga Furlow
SVP - General Counsel
9,079   Derivative/Non-derivative trans. at $108.49 per share. 984,980
07/07/2020 James T. Hippel
Chief Financial Officer
500   Disposition at $272.26 per share. 136,130
07/07/2020 James T. Hippel
Chief Financial Officer
1,663   Disposition at $271.4 per share. 451,338
07/07/2020 James T. Hippel
Chief Financial Officer
414   Disposition at $270.56 per share. 112,011
07/07/2020 James T. Hippel
Chief Financial Officer
2,577   Derivative/Non-derivative trans. at $108.49 per share. 279,578
07/06/2020 James T. Hippel
Chief Financial Officer
1,269   Disposition at $274.52 per share. 348,365
07/06/2020 James T. Hippel
Chief Financial Officer
1,934   Disposition at $273.71 per share. 529,355
07/06/2020 James T. Hippel
Chief Financial Officer
4,947   Disposition at $272.34 per share. 1,347,265
07/06/2020 James T. Hippel
Chief Financial Officer
3,781   Disposition at $271.53 per share. 1,026,654
07/06/2020 James T. Hippel
Chief Financial Officer
9,571   Disposition at $270.45 per share. 2,588,476
07/06/2020 James T. Hippel
Chief Financial Officer
21,502   Derivative/Non-derivative trans. at $108.49 per share. 2,332,751
05/29/2020 Harold J. Wiens
Director
3,985   Disposition at $260 per share. 1,036,100
05/29/2020 Norman David Eansor
President-Protein Sciences
709   Disposition at $264.01 per share. 187,183
05/29/2020 Norman David Eansor
President-Protein Sciences
2,100   Disposition at $262.68 per share. 551,628
05/29/2020 Norman David Eansor
President-Protein Sciences
3,400   Disposition at $261.74 per share. 889,916
05/29/2020 Norman David Eansor
President-Protein Sciences
1,700   Disposition at $260.83 per share. 443,411
05/29/2020 Harold J. Wiens
Director
3,985   Derivative/Non-derivative trans. at $101.19 per share. 403,242
05/29/2020 Norman David Eansor
President-Protein Sciences
7,909   Derivative/Non-derivative trans. at $108.49 per share. 858,047
05/28/2020 Brenda Swierenga Furlow
SVP - General Counsel
3,800   Disposition at $260.38 per share. 989,444
05/28/2020 Brenda Swierenga Furlow
SVP - General Counsel
2,195   Disposition at $259.72 per share. 570,085
05/28/2020 Norman David Eansor
President-Protein Sciences
3,448   Disposition at $260.19 per share. 897,135
05/28/2020 Brenda Swierenga Furlow
SVP - General Counsel
1,600   Derivative/Non-derivative trans. at $94.35 per share. 150,960
05/28/2020 Brenda Swierenga Furlow
SVP - General Counsel
5,995   Derivative/Non-derivative trans. at $108.49 per share. 650,397
05/28/2020 Norman David Eansor
President-Protein Sciences
3,448   Derivative/Non-derivative trans. at $108.49 per share. 374,073
05/26/2020 Charles R. Kummeth
Chief Executive Officer; Director
13,018   Derivative/Non-derivative trans. at $266.4 per share. 3,467,995
05/26/2020 Charles R. Kummeth
Chief Executive Officer; Director
21,159   Derivative/Non-derivative trans. at $86.25 per share. 1,824,963
05/22/2020 Harold J. Wiens
Director
378   Gift at $0 per share. 0
05/22/2020 Norman David Eansor
President-Protein Sciences
4,924   Disposition at $268.41 per share. 1,321,650
05/22/2020 Norman David Eansor
President-Protein Sciences
7,676   Disposition at $267.62 per share. 2,054,251
05/22/2020 Norman David Eansor
President-Protein Sciences
8,637   Derivative/Non-derivative trans. at $108.49 per share. 937,028
05/22/2020 Norman David Eansor
President-Protein Sciences
3,963   Derivative/Non-derivative trans. at $94.35 per share. 373,909
05/21/2020 Robert V. Baumgartner
Director
125   Disposition at $267.94 per share. 33,492
05/21/2020 Robert V. Baumgartner
Director
1,974   Disposition at $267.32 per share. 527,689
05/21/2020 Robert V. Baumgartner
Director
1,601   Disposition at $266.07 per share. 425,978
05/21/2020 Robert V. Baumgartner
Director
1,300   Disposition at $265.35 per share. 344,955
05/21/2020 Norman David Eansor
President-Protein Sciences
900   Disposition at $268.88 per share. 241,992
05/21/2020 Norman David Eansor
President-Protein Sciences
10,137   Disposition at $267.37 per share. 2,710,329
05/21/2020 Robert V. Baumgartner
Director
5,000   Derivative/Non-derivative trans. at $70.35 per share. 351,750
05/21/2020 Norman David Eansor
President-Protein Sciences
11,037   Derivative/Non-derivative trans. at $94.35 per share. 1,041,340
05/06/2020 Harold J. Wiens
Director
4,260   Disposition at $250 per share. 1,065,000
05/06/2020 Harold J. Wiens
Director
4,260   Derivative/Non-derivative trans. at $87.34 per share. 372,068

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
14 Purchases
34 Sales
105,980
96,528
Last 6 months
18 Purchases
39 Sales
120,906
111,996
Last 12 months
48 Purchases
70 Sales
289,683
233,261

Officers and Executives

Mr. Charles R. Kummeth
President, Chief Executive Officer & Director
Mr. James T. Hippel
CFO & Principal Accounting Officer
Dr. Robert Monroe
Chief Medical Officer
Mr. Kim Kelderman
President-Diagnostics & Genomics
Ms. Brenda Swierenga Furlow
Secretary, Senior Vice President & General Counsel
Mr. Robert M. Gavin
Senior Vice President-Analytical Systems Division
Mr. Kevin S. Gould
Senior Vice President-Diagnostics Division
Mr. David Clair
Investor Relations Contact
Dr. Alpna H. Seth
Independent Director
Mr. Robert V. Baumgartner
Chairman
Ms. Julie L. Bushman
Independent Director
Dr. Rupert J. Vessey
Independent Director
Dr. Randolph C. Steer
Independent Director
Mr. John L. Higgins
Independent Director
Dr. Roeland Nusse
Independent Director
Mr. Harold J. Wiens
Independent Director
Dr. Joseph D. Keegan
Independent Director
Link to MarketWatch's Slice.